Annaida Technologies SA Companies
Annaida Technologies SA has developed a groundbreaking device, EmbryoSpin, that performs microscopic Nuclear Magnetic Resonance at a scale 10-fold better than existing technologies, enabling non invasive chemical analysis at the scale of a single human embryo. Nuclear opens new global markets in assisted reproductive technology (“ARTâ€), enabling non-invasive embryo viability screening for in vitro fertilization (“IVFâ€), as well as in biochemical research.
Investors
.png)
.jpeg)
Industry:
Reproductive Health & Contraception
Headquarters:
Switzerland
Employee Number:
1-10
Founded Date:
2018